Mauricio Redondo-Müller

Title: Mauricio Redondo-Müller: Innovator in FGFR4 Inhibition Therapies

Introduction

Mauricio Redondo-Müller is a notable inventor based in Germering, Germany. He has made significant contributions to the field of medical therapies, particularly in the area of FGFR4 inhibition. With a total of two patents to his name, his work focuses on improving treatment outcomes for patients.

Latest Patents

Redondo-Müller's latest patents include a groundbreaking invention that combines an anti-FGFR4 antibody with a bile acid sequestrant. This invention aims to ameliorate the toxic effects associated with therapies targeting FGFR4 inhibition. Specifically, it addresses the combination of FGFR4 inhibitors and agents that can reduce bile acid levels, enhancing treatment efficacy for various diseases.

Career Highlights

Throughout his career, Mauricio Redondo-Müller has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Bioinvent International AB and Daiichi Sankyo Europe GmbH. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

Redondo-Müller has collaborated with various professionals in his field, including Reimar Abraham. These partnerships have facilitated the advancement of his research and the successful development of his patents.

Conclusion

Mauricio Redondo-Müller is a distinguished inventor whose work in FGFR4 inhibition therapies has the potential to significantly impact medical treatments. His innovative approach and dedication to improving patient outcomes are commendable.